Advertisement

What are the means of early detection of malignant degeneration?

  • C. G. Bremner
  • A. J. Cameron
  • R. E. Condon
  • J.-P. Favre
  • P. Rat
  • O. Haas
  • H. Viard
Conference paper

Abstract

The means of early detection of malignant degeneration in an established columnarlined esophagus (CLE) are far from satisfactory.

Keywords

Intestinal Metaplasia High Grade Dysplasia Malignant Degeneration Intramucosal Carcinoma Dysplastic Epithelium 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Skinner DB, Walther BC, Riddell RH, Schmidt H, Iascone C, DeMeester TR (1983) Barrett’s esophagus: comparison of benign and malignant cases. Ann Surg 198: 554–566PubMedCrossRefGoogle Scholar
  2. 2.
    Kawai K, Takemoto T, Suzuki S, Ida K (1979) Proposed nomenclature and classification of the dye-spraying techniques in endoscopy. Endoscopy 1: 23–25CrossRefGoogle Scholar
  3. 3.
    Haggitt RC, Tryzelaar J, Ellis FH Jr, Colcher H (1978) Adenocarcinoma complicating columnar epithelium-lined (Barrett’s) Esophagus. Amer J Clin Path 70(1): 1–5Google Scholar
  4. 4.
    Saubier EC, Gouillat C, Samaniego C, Guillaud M, Moulinier B (1985) Adenocarcinoma in columnar-lined Barrett’s esophagus. Analysis of 13 esophagectomies. Amer J Surg 150:365–369PubMedCrossRefGoogle Scholar
  5. 5.
    Lee RG (1985) Dysplasia in Barrett’s esophagus. A clinico-pathologic study of six patients. Am J Surg Path 9(12): 845–852PubMedCrossRefGoogle Scholar
  6. 6.
    Schmidt HG, Riddell RH, Walther BC, Skinner DB, Riemann IF (1985) Dysplasia in Barrett’s esophagus. J Amer Res Clin Oncol 110(2): 145–152CrossRefGoogle Scholar
  7. 7.
    Berenson MM, Herbst JJ, Freston JW (1975) Esophageal columnar epithelial B-galactosidase and B-glucuronidase. Gastroenterol 68(6): 1417–1419Google Scholar
  8. 8.
    Jass JR (1981) Mucin histochemistry of the columnar epithelium of the esophagus: a retrospective study. J Clin Path 34: 866–870PubMedCrossRefGoogle Scholar
  9. 9.
    Rothery GA, Patterson JE, Stoddard CJ, Day DW (1986) Histological and histochemical changes in the columnar-lined (Barrett’s) esophagus. Gut 27(9): 1062–1068PubMedCrossRefGoogle Scholar
  10. 10.
    Herbst JJ, Berenson MM, McCloskey DW, Wiser WC (1978) Cell proliferation in esophageal columnar epithelium (Barrett’s esophagus). Gastroenterol 75: 683–687Google Scholar
  11. 11.
    Sjogren RW, Johnson LF (1983) Barrett’s esophagus: A review. Am 1 Med 74: 313–321CrossRefGoogle Scholar
  12. 12.
    Mangla JC (1981) Barrett’s esophagus: an old entity rediscovered. J Clin Gastroenterol 3:347–356PubMedCrossRefGoogle Scholar
  13. 13.
    Cameron AJ, Ott BJ, Payne WS (1985) The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N Engl J Med 313(14): 857–859PubMedCrossRefGoogle Scholar
  14. 14.
    Spechler SJ, Robbins AH, Rubins HB, Vincent HE, Heerer etal (1984) Adenocarcinoma and Barrett’s esophagus: an overrated risk? Gastroenterol 87: 927–933Google Scholar

References

  1. 1.
    Skinner DB et al. (1983) Barrett’s esophagus. Comparison of benign and malignant cases. Ann Surg 198:554PubMedCrossRefGoogle Scholar
  2. 2.
    Sanfey M et al. (1985) Carcinoma arising in Barrett’s esophagus. Surg Gynecol Obstet 161:570PubMedGoogle Scholar
  3. 3.
    Hamilton SR, Smith RRL (1987) The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett’s esophagus. Amer J Clin Path 87: 301Google Scholar
  4. 4.
    Maimon HN et al. (1974) Positive esophageal cytology without detectable neoplasm. Gastroint Endosc 20: 156CrossRefGoogle Scholar
  5. 5.
    Nabeya K (1983) Markers of cancer risk in the esophagus and surveillance of high-risk groups. In: Precancerous lesions of the gastrointestinal tract. Sherlock P et al (ed) Raven Press New YorkGoogle Scholar
  6. 6.
    Korsten MA (1985) Balloon cytology in screening of asymptomatic alcoholics for esophageal cancer. Dig Dis Sci 30: 845PubMedCrossRefGoogle Scholar
  7. 7.
    Spechler SJ, Goyal RK (1986) Barrett’s esophagus. N Engl J Med 315: 366CrossRefGoogle Scholar
  8. 8.
    Lee RG (1985) Dysplasia in Barrett’s esophagus: A clinical pathologic study of six patients. Am J Surg Pathol 9: 845PubMedCrossRefGoogle Scholar
  9. 9.
    Reid BJ et al. (1986) Barrett’s esophagus: High grade dysplasia and intramucosal carcinoma detected by endoscopic biopsy surveillance. Gastroenterology 90: 601Google Scholar
  10. 10.
    Nebel OT et al. (1953) Symptomatic gastroesophageal reflux: Incidence and precipitating factors. Am J Dig Dis 21: 953CrossRefGoogle Scholar
  11. 11.
    Winters C et al. (1987) Barrett’s esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 92: 118PubMedGoogle Scholar

References

  1. 1.
    Spechler JS, Robbins AH, Rubins HB etal (1984) Adenocarcinoma and Barrett’s esophagus: An overrated risk? Gastroenterol 87: 927–933Google Scholar
  2. 2.
    Sarr MG, Hamilton SR, Marrone GC, Cameron JL (1985) Barrett’s esophagus: Its prevalence and association with adenocarcinoma in patients with symptoms of gastroesophageal reflux. Amer J Surg 185; 149: 187–193CrossRefGoogle Scholar
  3. 3.
    Cameron AJ, Ott BJ, Payne WS (1985) The incidence of adenocarcinoma in columnar-lined (Barrett’s) esophagus. N Engl J Med 313: 857–859PubMedCrossRefGoogle Scholar
  4. 4.
    Soergel K personal communicationGoogle Scholar
  5. 5.
    Mahoney JL, Condon RE (1987) Adenocarcinoma of the esophagus. Ann Surg 205: 557–562PubMedCrossRefGoogle Scholar

References

  1. 1.
    Brand DL, Ylvisaker IT, Gelfand M, Pope CE II (1980) Regression of columnar esophageal (Barrett’s) epithelium after anti-reflux surgery. New Engl J Med 302: 844–846PubMedCrossRefGoogle Scholar
  2. 2.
    Delpre G, Kadish U, Glanz I, Avidor L (1984) Prolonged cimetidine therapy in ulcerated Barrett’s columnar-lined esophagus. Amer J Gastroent 79: 8–11PubMedGoogle Scholar
  3. 3.
    Everhart CW, Humphries TJ (1978) Medical treatment of Barrett’s esophagus with betanechol. Report of three cases with prolonged follow-up. Gastroenterology 74: 1033–1035Google Scholar
  4. 4.
    Favre JP, Sala JJ, Haas O, Gouillat C, Viard H, Saubier EC Adenocarcinoma of lower esophagus and Barrett’s esophagus. Sous presse Digestive SurgeryGoogle Scholar
  5. 5.
    Hamilton SR, Hutcheon DF, Ravich WJ, Cameron JL, Paulson M (1984) Adenocarcinoma in Barrett’s esophagus after elimination of gastroesophageal reflux. Gastroenterology 86: 356–359PubMedGoogle Scholar
  6. 6.
    Holscher AH, Bader M, Siewert JR (1985) Kann Antireflux-chirurgie eine maligne Entartung des Endobrachyosophagus verhindern? Dtsch med Wschr 10: 551–555CrossRefGoogle Scholar
  7. 7.
    Naef AP, Savary M, Ozzelo C (1975) Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett’s esophagus with 12 adenocarcinomas. J Thorac Cardiosvasc Surg 70: 826–835Google Scholar
  8. 8.
    Patel GK, Clift SA, Schaefer RA, Read RC, Texter EC (1982) Resolution of severe dysplastic (Ca in situ) changes with regression of columnar epithelium (CE) in Barrett’s esophagus (BE) on medical treatment. Gastroenterology 82: 1147–1150Google Scholar
  9. 9.
    Potet F, Peuchmaur M (1984) Etude histochimique des mucines dans l’endobrachycesophage. Archives d’Anatomie et de Cytologie Pathologie 32: 59Google Scholar
  10. 10.
    Skinner DB, Walther BC, Riddell RH, Schmidt H, Iascone C, DeMeester TR (1985) Barrett’s esophagus. Comparison of benign and malignant cases. Ann Surg 198: 554–566CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • C. G. Bremner
    • 1
  • A. J. Cameron
    • 2
  • R. E. Condon
    • 3
  • J.-P. Favre
    • 4
  • P. Rat
    • 4
  • O. Haas
    • 4
  • H. Viard
    • 4
  1. 1.JohannesburgSouth Africa
  2. 2.RochesterUSA
  3. 3.MilwaukeeUSA
  4. 4.DijonFrance

Personalised recommendations